Mosaic Group: 2016
Mosaic Group
100 West 33rd Street, 5th floor
New York, NY 10001
Phone: 212-716-7600
Facsimile: 917-661-7200
Email: [email protected]
Website: mosaicgroupny.com
Accounts
Account wins 7
Active business clients 10
Brands by 2015 sales
Brand-product accounts held 16
$25 million or less 1
$25 million to $50 million 1
$50 million to $100 million 3
$100 million to $500 million 6
$500 million to $1 billion 1
$1 billion or more 2
Number of products yet to be approved/launched: 2
Services Mix
Access and Reimbursment 100%
Client Roster
Daiichi Sankyo
Depomed
Janssen
Novartis
Novocure
Relypsa
Sandoz
Sanofi Pasteur
Takeda
According to agency executives, Mosaic Group is focused on transforming evidence into value in the complex managed markets space for their clients. “With 30 percent revenue growth in 2015, the agency is in high gear and positioned to drive future growth based on this singular idea,” executives say.
Mosaic Group, an FCB Health company, is a full-service healthcare communications agency that specializes in helping brands achieve market access and reimbursement objectives. “Mosaic produces results for our clients by putting strategy first, developing evidence-based tactical initiatives, and delivering thought-provoking creative,” says Doug Jordan, managing director.
The year’s accomplishments
2015 was marked by successful partnerships on many fronts, starting with three groundbreaking product launches, executives say. Mosaic Group supported Sandoz in launching Zarxio, the first biosimilar approved in the U.S. market. “Interest is extremely high among payers and other managed care audiences, but knowledge about how to evaluate and incorporate biosimilars into policies and protocols is still in its infancy,” says Doug Wynn, R.Ph., Mosaic’s payer strategy director. Mosaic Group helped Sandoz develop and deploy educational resources for organized customers about considerations for biosimilar evaluation, while also promoting the value proposition for Zarxio.
Mosaic Group also worked on Novartis’ first-in-class heart failure medication, Entresto, as agency of record supporting the product’s launch in hospitals, health systems, and heart failure clinics. “With the continuing move toward value-based payment, health systems need to fully understand the potential clinical and economic benefits of new treatment options, such as Entresto,” Wynn says.
For Boehringer Ingelheim, Mosaic Group led payer communications for Ofev, a new treatment for idiopathic pulmonary fibrosis (IPF), an orphan disease. Because IPF was not well understood with no treatment options available prior to the launch of Ofev, agency leaders say Mosaic developed a unique resource to help formulary decision-makers educate themselves via an online resource center. Thousands of downloads by managed care professionals were made from the site to help establish a base of knowledge for informed payer evaluations of Ofev once the drug was approved. Mosaic also executed an extensive personal and non-personal branded campaign to help augment account manager efforts following approval to strengthen communication of the value proposition for Ofev.
In recent months Mosaic Group has won several new assignments including Sanofi Pasteur’s Fluzone High-Dose, Relypsa’s hyperkalemia drug, Veltassa, and Janssen’s HIV treatment, Prezcobix, and is continuing to expand its relationships with existing clients Boehringer Ingelheim, Daiichi Sankyo, and Takeda, executives say.
“We’re proud of our accomplishments and innovative work we created in 2015, and are already well on our way to continue that to exceed our performance this year,” Jordan says.
Structure and services
Mosaic Group’s leaders say they believe in “strategy first” for all of the agency’s engagements, and has built a multidisciplinary strategy team lead by Wynn, who is a former UnitedHealthcare pharmacy director. The team also includes senior account staff, medical directors, digital strategy directors, and new creative director, Denise Lenci.
Lenci joined Mosaic in 2015 to manage the agency’s talented staff of copywriters and artists. “My job is to bring strategy to creative, and vice versa,” Lenci says. Executives say she has more than 20 years of experience in managed markets, medical, and science communications, having previously worked at two other leading healthcare agencies and managed her own boutique agency.
Also new to the Mosaic leadership team in 2015 was David Quirk, senior VP, account group supervisor. Quirk brings more than 20 years of pharmaceutical industry experience, including over 10 years in payer marketing and communications, to the agency. He previously held leadership positions in other managed markets agencies and at a sales support company where he developed managed markets training and education programs.
In addition to the leadership and strategy teams, Mosaic Group is staffed by more than 30 account, creative, project management, and operations professionals solely focused on managed markets communications.
According to agency leaders, one of Mosaic Group’s unique offerings is Access 360º, a multi-disciplinary panel of more than 500 managed care decision makers from both traditional and emerging managed care segments – health insurers, ACOs, hospitals, integrated delivery systems, etc. Panelists include medical and pharmacy directors, department chairs, HEOR and quality directors, clinical/MTM pharmacists, policy-makers/guideline committee members, and case managers, among others. “Our Access 360 panel is available on demand to provide insights and to validate the impact of proposed strategy,” Wynn says.
Executives say for more in-depth strategic assessment, Mosaic offers “Infocus Forums” – On-demand steering committees comprised of nationally recognized segment and subject matter experts (often drawn from the Access 360º panel) that are convened to provide clarity and strategic guidance on brand/market event challenges.
“Mosaic uses strategic insights to build or enrich a value platform for each client/brand; the platform serves as the foundation for all access and reimbursement communications,” executives say. “Through proprietary workshops and other techniques, Mosaic Group develops a unique value proposition and value messages, which are subsequently brought to life through creative executions implemented across all media and channels.”
Leaders say the agency is strengthened by its membership in the FCB Health network. “We have access to some of the most forward-thinking and creative folks in the business, as well as cutting edge technology,” Lenci says. “This enables us to bring a level of creativity not often seen in managed markets.”
Future plans
According to agency leaders, the future of Mosaic Group is tied to the future of managed care, which is in the midst of great change. “The migration to quality- and value-based payment models is accelerating, health plans and health care systems are consolidating, patient cost sharing is increasing,” executives say.
“As the saying goes, ‘with change comes opportunity,’” Jordan says. “At Mosaic, we are future-focused. We’re putting in place today the resources that will be important to our clients tomorrow.”
Mosaic is expanding its strategic capabilities in health system marketing and further building its already strong creative team. Leaders say they expect to continue to build upon the agency’s previous success during 2016.
